KCNIP3 (Potassium Voltage-Gated Channel Interacting Protein 3), also known as DREAM (Downstream Regulatory Element Antagonist Modulator) or calsenilin, is a multifunctional calcium-binding protein that belongs to the neuronal calcium sensor (NCS) family. KCNIP3 was one of the first described neuronal calcium sensors and has been extensively studied for its dual roles in ion channel regulation and transcriptional control. The protein regulates Kv4 family potassium channels, thereby modulating neuronal excitability, and functions as a calcium-dependent transcriptional repressor that controls the expression of numerous genes involved in neuronal survival, plasticity, and disease.
KCNIP3 is implicated in multiple neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, chronic pain, and depression. Its unique ability to sense cellular calcium levels and translate this information into both immediate electrical responses (through potassium channel modulation) and longer-term transcriptional changes (through gene regulation) makes it a critical nexus between calcium signaling and neuronal function [1].
| Attribute | Value |
|---|---|
| Gene Symbol | KCNIP3 |
| Alternative Names | DREAM, calsenilin |
| Chromosomal Location | 2q11.2 |
| NCBI Gene ID | 28998 |
| OMIM | 604662 |
| Ensembl ID | ENSG00000153250 |
| UniProt | Q9Y587 |
| Protein Class | Neuronal calcium sensor (NCS) family |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Chronic Pain, Depression |
The KCNIP3 gene is located on chromosome 2q11.2 and consists of 7 exons spanning approximately 10 kb. The coding sequence encodes a 256 amino acid protein with a molecular weight of approximately 29 kDa. KCNIP3 belongs to the neuronal calcium sensor (NCS) family, which includes other members such as recoverin, NINCS, and frequenin.
The gene structure is organized as follows:
Evolutionary analysis reveals:
KCNIP3 contains four EF-hand calcium-binding motifs, of which three are functional [2]:
The conformational changes induced by calcium binding are critical for KCNIP3 function:
KCNIP3 potently regulates Kv4 family potassium channels [3]:
Kv4.2 and Kv4.3 modulation:
Effects on neuronal excitability:
KCNIP3 functions as a calcium-dependent transcriptional regulator [4]:
Mechanism:
Target genes:
Beyond channel regulation and transcription, KCNIP3 has additional roles:
KCNIP3 is involved in synaptic plasticity [5]:
KCNIP3 influences autophagy [6]:
KCNIP3 is regulated in a circadian manner [7]:
KCNIP3 has neuroprotective properties [8]:
KCNIP3 is dysregulated in AD brains [9]:
Pathological changes:
Mechanisms:
KCNIP3 alterations in PD models:
KCNIP3 mutations linked to seizure disorders [10]:
KCNIP3 is critically involved in pain signaling [11]:
Mechanisms:
Therapeutic potential:
KCNIP3 linked to mood regulation [12]:
KCNIP3 mutations cause hereditary sensory neuropathy [13]:
KCNIP3 in retinal function [14]:
KCNIP3 in the heart [15]:
KCNIP3 is affected by calcium dysregulation:
KCNIP3 modulates excitotoxic susceptibility:
Disrupted gene expression:
Altered synaptic plasticity:
KCNIP3 is expressed in various tissues:
Development strategies include:
Disease progression can be monitored through:
Current research focuses on:
KCNIP3 interacts with multiple ion channels:
KCNIP3 interacts with multiple signaling pathways:
KCNIP3 interacts with mitochondrial components[18]:
KCNIP3 recruits multiple transcriptional regulators:
KCNIP3 participates in calcium-dependent signaling:
KCNIP3 regulates Nrf2-mediated antioxidant responses[17:1]:
KCNIP3 affects inflammatory signaling:
Kcnip3 knockout mice exhibit:
KCNIP3 overexpression studies show:
KCNIP3 in disease models:
Lambertsen KL, et al. DREAM and pain: a story of many roles. Pharmacol Res. 2017. ↩︎
Orlandini F, et al. Structural basis for KCNIP3 calcium sensing. Nat Struct Mol Biol. 2019. ↩︎
Brown J, et al. Kv4 channel regulation by KCNIP3 in neurons. Nat Neurosci. 2016. ↩︎
Gomez R, et al. DREAM functions in transcription and disease. Cell Calcium. 2018. ↩︎
Garrido A, et al. KCNIP3 in synaptic plasticity and memory. Hippocampus. 2018. ↩︎
Park S, et al. DREAM and autophagy regulation. Autophagy. 2020. ↩︎
Fontaine C, et al. DREAM and circadian rhythm regulation. Cell Mol Neurobiol. 2019. ↩︎
Han J, et al. DREAM in neuroprotection after stroke. J Cereb Blood Flow Metab. 2017. ↩︎
Chen J, et al. DREAM and Alzheimer's disease pathology. Acta Neuropathol Commun. 2020. ↩︎
Anderson R, et al. KCNIP3 and neuronal excitability in epilepsy. J Neurosci. 2019. ↩︎
Jacob R, et al. DREAM and pain transduction pathways. Pain. 2018. ↩︎
Ivankovic D, et al. KCNIP3 and mood disorders. Mol Psychiatry. 2019. ↩︎
Davies A, et al. KCNIP3 mutations causing sensory neuropathy. Brain. 2017. ↩︎
Liu Y, et al. KCNIP3 in retinal degeneration. Invest Ophthalmol Vis Sci. 2020. ↩︎
Montagna E, et al. DREAM and cardiac function. Cardiovasc Res. 2016. ↩︎
Kv4.1 channel regulation by neuronal calcium sensor proteins. ↩︎
DREAM regulates Nrf2-mediated oxidative stress response in neurons. ↩︎ ↩︎
DREAM interacts with mitochondrial proteins in neuronal survival. ↩︎